https://cureduchenne.org/blog/prosensa-begins-nda-submission-to-the-fda-for-exon-skipping-drug-drisapersen-to-treat-duchenne-muscular-dystrophy/
Prosensa begins NDA submission to the FDA for exon-skipping drug drisapersen to treat Duchenne...
Oct 10, 2014 - CureDuchenne is delighted to share the news that Prosensa announced today that it has begun the submission process for a New Drug Application filing to the FDA...
to theexon skippingprosensabeginsnda